Cargando…
RF10 | PMON205 LH/CG Receptor Activation Protects Mice from Diet-Induced Obesity and Modifies Adipose Tissue Immune Response
Menopause is associated with the loss of LH ovulatory surges and enhanced visceral adiposity. Visceral fat depots increase from 5-8% at premenopause to 15-20% of total body fat at postmenopause. Here, we report that high-dose LH, hCG, or small molecule LH/CGR agonist ORG43553 injected twice-a-week i...
Autores principales: | Lizneva, Daria, Ievleva, Kseniia, Gumerova, Anisa, Shelly, Eleanor, Korkmaz, Funda, Muradova, Valeriia, Netto, Jessica, Kuo, Tanchun, Sultana, Farhath, Kumar, Pushkar, Kramskiy, Natan, Ryu, Vitaly, Padilla, Ashley, Hutchison, Susan, Yuen, Tony, Zaidi, Mone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624535/ http://dx.doi.org/10.1210/jendso/bvac150.058 |
Ejemplares similares
-
SAT649 Org43553, The First Low-molecular-weight Agonist Of The Human Luteinizing Hormone Receptor Induces Leanness And Energy Expenditure In Mice
por: Lizneva, Daria, et al.
Publicado: (2023) -
SAT669 Development And Biophysical Characterization Of A Humanized FSH-blocking Monoclonal Antibody Therapeutic Formulated At An Ultra-high Concentration
por: Rojekar, Satish, et al.
Publicado: (2023) -
PMON51 A Single Multipurpose FSH–Blocking Therapeutic for Osteoporosis, Obesity and Alzheimer's Disease
por: Korkmaz, Funda, et al.
Publicado: (2022) -
SAT668 Can We Treat Osteoporosis, Obesity And Neurodegeneration With A Single FSH-blocking Drug?
por: Rani Pallapati, Anusha Rani, et al.
Publicado: (2023) -
FRI001 Tanycytic Thyroid-stimulating Hormone Receptor Activation Increases Blood-Hypothalamus Barrier Permeability And Induces Appetite In Female Mice
por: Kannangara, Hasni Suhasha, et al.
Publicado: (2023)